ABVC BioPharma
ABVC
ABVC
5 hedge funds and large institutions have $1.56M invested in ABVC BioPharma in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
5
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.13M | |
| 2 | +$45.1K | |
| 3 | +$26K | |
| 4 |
Morgan Stanley
New York
|
+$5K |
Top Sellers
| 1 | -$165K | |
| 2 | -$44K | |
| 3 | -$35K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$27K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8K |